Ge Healthcare Technologies Inc. premarket rises 1.29% after Agilent introduces new ProteoAnalyzer for protein analysis in pharma and biopharma.

Ge Healthcare Technologies Inc. experienced a 1.29% increase in premarket trading. The positive movement was likely influenced by Agilent Technologies' announcement of their new ProteoAnalyzer system at the Singapore Cell and Gene Therapy Pan Asia Summit. The advanced protein analysis platform, designed to enhance protein research in pharma and biopharma sectors, could boost the perception of Ge Healthcare's involvement in cutting-edge technologies. However, unrelated news about Ryanair's profit miss and Boeing's defense unit challenges do not seem to have a direct impact on Ge Healthcare's stock.